Kura Oncology, Inc.
Symbol: KURA (NASDAQ)
8.75
▼ (-1.13%) -0.100
Company Description:
Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.
Key Stats
- Today's Open: $8.73
- Today's High: $8.87
- Today's Low: $8.73
- Today's Volume: 584
- Yesterday Close: $8.85
- Yesterday High: $9.04
- Yesterday Low: $8.585
- Yesterday Volume: 1.82M
- Last Min Volume: 0
- Last Min High: $8.788
- Last Min Low: $8.75
- Last Min VWAP: $0
Company Profile
- Name: Kura Oncology, Inc.
- Website: https://www.kuraoncology.com
- Listed Date: 2015-08-25
- Location: SAN DIEGO, CA
- Market Status: Active
- CIK Number: 0001422143
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $768.16M
- Round Lot: 100
- Outstanding Shares: 86.80M
- Asset Type: CS
RECENT FILINGS FOR KURA
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-09-29 | 144 | View |
| 2025-09-29 | 144 | View |
| 2025-09-29 | 144 | View |
| 2025-09-29 | 144 | View |
| 2025-09-29 | 144 | View |
| 2025-09-29 | 144 | View |
| 2025-09-29 | 4 | View |
| 2025-09-29 | 4 | View |
| 2025-09-29 | 4 | View |
| 2025-09-29 | 4 | View |
| 2025-09-29 | 4 | View |
| 2025-09-29 | 4 | View |
| 2025-09-09 | 4 | View |
| 2025-08-15 | SCHEDULE 13G/A | View |
| 2025-08-14 | 4 | View |
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-07 | 10-Q | View |
| 2025-08-07 | 8-K | View |
| 2025-07-01 | 8-K | View |
| 2025-06-18 | 8-K | View |
Latest News on KURA